Gustavo Campos

Gustavo Campos

Auto-generated profile, based on publicly available information

Gustavo Campos

Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2025 in Nature Medicine
Verified
Journal Article
Open access
PDF file
WCWonkyung Choi
Wonkyung Choi
YNYoung-Hoon Nho
Young-Hoon Nho
LQLiming Qiu
Liming Qiu
ACAndrew Chang
Andrew Chang
GCGustavo Campos
Gustavo Campos
CHCasey H. Halpern
Casey H. Halpern
Obesity and related conditions are associated with distressing food preoccupation that often culminates in dysregulated eating behaviors. Incretin-based therapies can reduce excessive weight in obesity, but their impact on dysregulated eating behaviors remains largely unexamined. Understanding how these pharmacologics engage the brain’s mesolimbic circuitry may inform the expansion of their therapeutic potential. We report a rare, first-in-human exploration of the physiological action of these therapies by examining the electrophysiology directly within the human nucleus accumbens. After a short-term course of tirzepatide, the patient-participant exhibited increased severe food preoccupation episodes, which were preceded by an increased delta–theta frequency (≤7 Hz) power in the nucleus accumbens region. We propose that the effects of an incretin-based therapy (tirzepatide) on food preoccupation may be associated with modulation of aberrant activity within this key hub of human mesolimbic circuitry.